Eastman Chemical Company

EMN Basic Materials Specialty Chemicals

Eastman Chemical Company’s revenue for fiscal 2025 (year ended December 2025) was $8.8 billion, down 6.71% from fiscal 2024. In the quarter to June 2026, revenue grew 9.88%, EPS grew 31.2%, free cash flow grew 49.4% and total debt fell 6.90%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.

62.33 1.54 −2.41%
Market cap
$7.3B
P/E
16.1×
Fwd P/E
11.5×
Dividend yield
5.39%
F-score
5/9
Altman Z
2.29
Beneish M
−2.66
Dividend safety
41/100

Insider Decisions trades per month

Total sells 0.37
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — 1 — — 1 — —
Insider Ownership 0.87%

Capital & Financial Ratios $m

Market Cap 7,310.00
Revenue 8,865.00
Net Income 443.00
Free Cash Flow 539.00
Net Debt 3,761.00
Current Ratio 1.50
Debt/Equity 0.72
P/E ratio 16.11
Fwd P/E 11.50
P/S ratio 0.80
P/B ratio 1.15
Past 5Y EPS Growth 3.22%
This Y EPS Growth 17.06% (at or above 15%: strong)
Next Y EPS Growth 6.05%
Next Y revenue growth 5.72%
Next 5Y EPS Growth 11.11%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 73.61%
10-year low 10-year high
P/S against its own 10 years 3.65%
10-year low 10-year high
P/B against its own 10 years 1.18%
10-year low 10-year high
EV/Sales against its own 10 years 2.43%
10-year low 10-year high
EV/FCF against its own 10 years 44.19%
10-year low 10-year high

Dividends

Payout Ratio 0.88
Annual Dividend Rate 3.36
Annual Dividend Yield 5.39%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 3.37
0.84
0.84
0.84
2025 3.33
0.83
0.83
0.83
0.84
2024 3.26
0.81
0.81
0.81
0.83
2023 3.18
0.79
0.79
0.79
0.81
2022 3.07
0.76
0.76
0.76
0.79
2021 2.83
0.69
0.69
0.69
0.76
2020 2.67
0.66
0.66
0.66
0.69
2019 2.52
0.62
0.62
0.62
0.66
2018 2.30
0.56
0.56
0.56
0.62
2017 2.09
0.51
0.51
0.51
0.56
2016 1.89
0.46
0.46
0.46
0.51
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 548 837 566 691
Receivables 1,154 1,172 999 1,365
Inventory 1,683 1,988 1,980 2,101
Other 96 104 100 98
3,481 4,101 3,645 4,255
2023 2024 2025 Q'26
Payables 2,035 2,258 2,066 2,075
ST’ Debt — — — —
Other — — — —
2,576 2,708 2,652 2,840

Compound Annual Growth %

10y 5y 3y
Sales (0.97%) 0.65% (6.13%)
Cash Flow (5.02%) (7.79%) (0.17%)
Earnings (5.65%) (0.17%) (15.76%)
Book Value 4.15% (0.23%) 4.86%

Revenue $m

Mar Jun Sep Dec Year
’26 2,177 2,513 — — —
’25 2,290 2,287 2,202 1,973 8,752
’24 2,310 2,363 2,464 2,245 9,382
’23 2,412 2,324 2,267 2,207 9,210
’22 2,714 2,784 2,709 2,373 10,580
’21 2,409 2,653 2,720 2,694 10,476
’20 2,241 1,924 2,122 2,186 8,473
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (137) 224 — — —
’25 (167) 233 402 502 970
’24 (16) 367 396 540 1,287
’23 (2) 410 514 452 1,374
’22 17 245 256 457 975
’21 216 426 547 430 1,619
’20 171 436 442 406 1,455
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (240) 124 — — —
’25 (314) 83 265 390 424
’24 (201) 252 276 361 688
’23 (178) 169 278 277 546
’22 (98) 106 92 264 364
’21 119 313 424 185 1,041
’20 70 337 364 288 1,059
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.93 1.59 — — —
’25 1.57 1.20 0.40 0.92 4.10
’24 1.39 1.94 1.53 2.82 7.67
’23 1.12 2.27 1.49 2.61 7.49
’22 1.80 2.03 2.46 0.01 6.35
’21 1.99 (1.07) 2.57 2.81 6.25
’20 1.89 0.20 1.18 0.23 3.50
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 56.03 74.78 67.40 61.22 34.44 96.27 69.91 68.89 80.71 56.11

Analyst estimates 2026–2028

Powerpack
High 78.79 94.96 112.45 86.18 104.83 130.47 129.48 92.21 114.50 103.82
People
People Employees 14,000 14,000 14,500 14,500 14,500 14,000 14,500 14,000 14,000 13,000
Revenue/emp, $m 0.64 0.68 0.70 0.64 0.58 0.75 0.73 0.66 0.67 0.67
Income, $m
Income, $m Revenue 9,008 9,549 10,151 9,273 8,473 10,476 10,580 9,210 9,382 8,752
Gross margin, % 26.17 24.75 24.42 24.09 23.31 23.86 20.20 22.38 24.41 21.07
EBT 1,049 1,289 1,310 902 530 1,082 977 1,087 1,078 568
EBT margin, % 11.65 13.50 12.91 9.73 6.26 10.33 9.23 11.80 11.49 6.49
Net income 859 1,388 1,084 762 489 867 796 896 908 475
Depreciation 580 587 604 611 574 538 477 498 509 513
Per share, $
Per share, $ Revenue 61.15 65.95 71.89 67.49 62.53 77.66 85.67 77.66 80.39 76.30
Earnings 5.88 10.18 7.65 5.52 3.53 6.35 6.42 7.54 7.75 4.14
Cash flow 9.40 11.44 10.93 10.95 10.74 12.00 7.89 11.59 11.03 8.46
Capex (3.97) (4.39) (3.70) (3.14) (2.92) (4.28) (4.95) (6.98) (5.13) (4.76)
Free cash flow 5.43 7.06 7.22 7.81 7.82 7.72 2.95 4.60 5.90 3.70
Book value 31.28 37.85 41.63 43.90 45.08 42.91 42.40 46.63 50.15 52.63
Shares, m 147 145 141 137 136 135 124 119 117 115
Valuation, ×
Valuation, × P/E 12.91 9.24 9.58 14.38 28.49 18.92 12.91 11.85 11.77 15.42
P/S 1.24 1.43 1.02 1.17 1.60 1.56 0.96 1.15 1.14 0.84
P/B 2.43 2.49 1.76 1.81 2.22 2.82 1.94 1.92 1.82 1.21
EV/Sales 1.92 2.05 1.58 1.76 2.16 1.93 1.29 1.56 1.53 1.25
EV/FCF 21.64 19.18 15.71 15.19 17.27 19.47 37.57 26.30 20.91 25.84
Cash, $m
Cash, $m Operating cash flow 1,385 1,657 1,543 1,504 1,455 1,619 975 1,374 1,287 970
Capex (585) (635) (523) (431) (396) (578) (611) (828) (599) (546)
Free cash flow 800 1,022 1,020 1,073 1,059 1,041 364 546 688 424
Balance, $m
Balance, $m Working capital 1,071 1,161 1,514 1,532 1,503 1,675 527 905 1,393 993
Total debt 6,311 6,147 5,925 5,611 5,269 4,412 4,025 4,305 4,567 4,201
Net debt 6,130 5,956 5,699 5,407 4,705 3,953 3,532 3,757 3,730 3,635
Shareholders’ equity 4,608 5,480 5,878 6,032 6,108 5,788 5,236 5,530 5,852 6,037
Returns, %
Returns, % ROA 5.50 8.80 6.75 4.74 2.98 5.42 5.25 6.10 6.06 3.15
ROIC 8.08 8.36 8.38 6.12 4.28 11.65 8.57 6.59 8.34 5.01
ROE 19.79 27.44 19.02 12.75 7.87 14.41 14.39 16.61 15.90 7.97
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Eastman Chemical Company vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
SOLS Solstice Advanced Materials Inc. $9.5B 27.4× 27.8× +11.13% (above 0%: growing) −14.99% (below 0%: shrinking) +70.83% (above 0%: growing) 32.23% 17.16% Compare
ESI Element Solutions Inc. $8.7B 47.4× 33.3× +56.41% (above 0%: growing) +60.00% (above 0%: growing) +29.19% (above 0%: growing) 34.15% 11.63% Compare
SQM Sociedad Quimica y Minera S.A. $8.6B 11.3× 12.1× +138.12% (above 0%: growing) +381.25% (above 0%: growing) −63.75% (below 0%: shrinking) 51.05% 48.62% Compare
NEU NewMarket Corporation $8.2B 18.8× — (loss-making) +6.96% (above 0%: growing) +22.80% (above 0%: growing) −6.94% (below 0%: shrinking) 32.45% 21.91% Compare
WLK Westlake Corporation $8.1B — (loss-making) 24.8× +10.77% (above 0%: growing) n/m +184.09% (above 0%: growing) 19.93% 11.13% Compare
EMN Eastman Chemical Company $7.3B 16.1× 11.5× +9.88% (above 0%: growing) +31.15% (above 0%: growing) +49.40% (above 0%: growing) 22.28% 12.38%
AXTA Axalta Coating Systems Ltd. $7.2B 20.5× 13.6× +3.14% (above 0%: growing) −16.00% (below 0%: shrinking) +7.22% (above 0%: growing) 34.55% 12.41% Compare
SXT Sensient Technologies Corporation $5.7B 36.0× 28.5× +11.55% (above 0%: growing) +35.96% (above 0%: growing) −64.25% (below 0%: shrinking) 37.40% 16.60% Compare
BCPC Balchem Corporation $5.4B 33.5× 30.5× +11.17% (above 0%: growing) +18.80% (above 0%: growing) −11.98% (below 0%: shrinking) 36.51% 20.85% Compare
Median of peers $8.1B 27.4× 27.8× +11.15% +22.80% +0.14% 34.35% 16.88%

All 60 Specialty Chemicals stocks →

Eastman Chemical Company (EMN) key facts

  • Concern: Eastman Chemical Company’s revenue for fiscal 2025 (year ended December 2025) was $8.8 billion, down 6.71% from fiscal 2024.
  • Concern: Net income was $475.0 million, or $4.14 per share (basic), a net margin of 5.42%.
  • Eastman Chemical Company (EMN) is a Specialty Chemicals company in the Basic Materials sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, EMN traded at $62.33, a market capitalization of $7.3 billion.
  • At that price the stock trades at 16.1× trailing-twelve-month earnings and 0.8× sales; its P/E is higher than 74% of its own readings over the past ten years.
  • Eastman Chemical Company pays an annual dividend of $3.36 per share, a yield of 5.39%, with a payout ratio of 87.5%.
  • Return on equity was 7.97% and debt-to-equity 0.72.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 2.29 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Eastman Chemical Company (EMN) Latest News

15 Sep

7 Aug

Impact 3 · transcript

7 May

Impact 2 ·
stockrow.com/EMN · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com